Please Wait...

Lauren Chazal

Translation skills

Main profile

Lauren Chazal
Director, Business Development, Global Clinical Research

Lauren Chazal MBA has a strong command of the clinical trials industry from a site operations, business development and financial management perspective. She began her career in clinical trial operations with a privately-held multi-site clinical research organization. Since 2012, she has held a pivotal role in business development and relationship management for clinical research sites globally. Lauren has in-depth knowledge of the complex interactions between clinical research centers, CROs and sponsors combined with a keen understanding of the importance of access to high quality trial sites and patient recruitment solutions. Lauren graduated from Lehigh University in 2005 with a bachelor's degree in Finance and Marketing and in 2009 from University of Florida with a Master's in Business Administration.

Blogs

Latin America: Benefit from the Right Partner

Latin America is a geographical region with a largely untapped population for clinical trials, and it has experienced tenfold growth in clinical trials since 2000.1 However, according to clinicaltrials.gov, there are currently only approximately 3,500 studies being conducted in all of Latin America, compared with the approximate 30,000 in the United States alone.

Respiratory syncytial virus (RSV) is increasingly being recognized as an important cause of disease in older adults worldwide. Its impact is estimated to be comparable to or even greater than that of influenza. However, RSV is not typically tested for, as there is no specific treatment.

How many investigative sites will you need for your next clinical trial? Will you choose independently-operated sites or a network of sites? Do you know their differences and advantages? We polled our Research Network customers and staff, and share what they said in this blog.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SchulmanIRB: #FDA final rule requires #medicaldevice #research conducted outside US to conform with GCP standards | via @RAPSorg https:…
bioclinica (14 hours ago)
RT @manchempharma: Paul Brooks, Executive Director, @RAPSorg comments on Brexit and the operational trade and regulatory environment affect…
bioclinica (14 hours ago)
RT @eClinical_Jen: Clinical Data Management articles available on SCDM Website - While all articles are available to members, there are sel…
bioclinica (14 hours ago)
Live from Las Vegas where Bioclinica's Research Development Director Marieke Cajal, PhD, is presenting on site star… https://t.co/lVglg6NWdV
bioclinica (15 hours ago)
Many thanks all who attended @bioclinica's Executive Roundtable on Safety Mgmt for Pharma Cos in Japan in Tokyo th… https://t.co/OzHeSvHTUk
bioclinica (15 hours ago)
RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (17 hours ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen